Chemed
215 hedge funds and large institutions have $2.3B invested in Chemed in 2015 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 79 increasing their positions, 81 reducing their positions, and 23 closing their positions.
80% more call options, than puts
Call options by funds: $2.35M | Put options by funds: $1.31M
39% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 23
4% more funds holding
Funds holding: 207 → 215 (+8)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less capital invested
Capital invested by funds: $2.33B → $2.3B (-$33.3M)
2% less repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 81
2.25% less ownership
Funds ownership: 104.35% → 102.09% (-2.3%)
Top Buyers
Top Sellers
CHE Hedge Fund Activity: Q3 2015 in Review
215 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q3 2015, worth a combined $2.3B — down 1.4% from $2.33B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new CHE positions and 23 closed out — a net gain of 9 holders — while 79 added to existing stakes and 81 trimmed.
The largest buyer was Boston Trust Walden, opening a new position worth an estimated $26.3M. The largest seller was Cardinal Capital Management LLC (Connecticut), exiting entirely with an estimated $31.6M sold.
- 215 institutional investors held Chemed (CHE) as of Q3 2015, up from 207 in Q2 2015.
- Funds reported $2.3B of Chemed stock for Q3 2015, down 1.4% quarter-over-quarter.
- 32 funds opened new Chemed positions in Q3 2015 and 23 closed out, a net change of +9 holders.
- The largest Chemed buyer in Q3 2015 was Boston Trust Walden, an estimated $26.3M added.
- The largest Chemed seller in Q3 2015 was Cardinal Capital Management LLC (Connecticut), an estimated $31.6M sold.
Based on aggregated 13F filings for Q3 2015.